not indexed in PubMed as of July 2026)
Topline Ozempic drugmaker Novo Nordisk filed a motion in federal court, days after it sued rival GLP-1 manufacturer Eli Lilly, urging a judge to block the companys allegedly deceptive advertisements that Novo says use outdated data to make its products look less effective
Meanwhile, clinical trials have pointed to GLP-1 agonist benefits in other indications, including chronic kidney disease, metabolic dysfunction-associated steatohepatitis (MASH), Parkinsons disease, Alzheimers, and addiction
Chronically high and low IGF-1 levels increase risk of death in adults (3)
Not following these protocols can result in ineffective or contaminated results just like a restaurant serving spoiled food would lead to poor customer experiences
My mental health was just depleted at that time, and food became even more of a comfort for me